designing a novel chimeric antigen to stimulate the immune system against brucella infection
نویسندگان
چکیده
brucellosis is a well-known infectious disease among domestic animals caused by brucella bacterium. omp25 is an outer membrane protein of brucella which plays an important role in immunogenicity of cells. moreover, brucella lumazine synthase (bls) as another main antigen can be used as an adjuvant when covalently attached to a foreign antigen. in the current study, designing and production of a chimeric construct as a primary step to stimulate the immune system against brucella infection is investigated. the construct was amplified by specific primers using soe-pcr technique. the amplified construct was cloned in ptz57r/t vector and transformed into e. coli top10f’ as cloning host. then, the construct was subcloned in pet-32a (+) vector followed by transforming into e. coli bl21 (de3) as expression host. our results demonstrated omp25-bls with 1163 bp was successfully cloned and expressed in the expression host. results were confirmed using sequencing, sds-page and western blotting which correctly showed 59 kd protein band of omp25-bls. according to our results this construct could be proposed to investigate as a new subunit vaccine candidate in order to stimulate immune system against brucellosis in future studies.
منابع مشابه
Design and Production of a Novel Recombinant Chimeric IL2-Omp31 Antigen against Brucella Infection
Brucellosis is a zoonotic disease in human and animals. Brucella melitensis is one of the most pathogenic species of Brucella in goat and sheep. Omp31 is an outer membrane protein of Brucella that acts as an immunogenic protein. Cytokines are glycoproteins with low molecular weight that play the role of an immune adjuvant and regulate immune responses. Interleukin-2 is one of the most important...
متن کاملHow to Boost Your Immune System Against Corona-virus Infection?
New emerging viruses like coronavirus 2019 (COVID-19) infections are always frightening. We know little about theirtransmission, behaviors, clinical manifestations, and outcomes. There is no vaccine or therapeutic strategies to dealwith these infections yet. In this situation, preventive measures may be promising. Hand hygiene is a very importantissue in preventing viral infec...
متن کاملInduction of Specific Humoral Immune Response in Mice against a Pseudomonas aeruginosa Chimeric PilQ/PilA Protein
Background: Pseudomonas aeruginosa, an opportunistic pathogen, is a common cause of healthcare-associated infections in immunocompromised individuals. The rapid emergence of multidrug-resistant strains has made P. aeruginosa infections progressively difficult to treat. In this study we evaluated the effect of a chimeric protein containing a P. aeruginosa PilQ fragment and the PilA disulfide loo...
متن کاملPriming Hepatitis B Surface (HBsAg)- and Core Antigen (HBcAg)-Specific Immune Responses by Chimeric, HBcAg with a HBsAg ‘a’ Determinant
We developed an immunogen to stimulate multivalent immunity against hepatitis B surface antigen (HBsAg) and hepatitis B core antigens (HBcAg). Immune responses specific for both HBsAg and HBcAg play an important role in controlling the infection. HBsAg-specific antibodies mediate elimination of virions at an early stage of infection and prevent the spread of virus. The immunogen was constructed...
متن کاملimmunoreactivity evaluation of a new recombinant chimeric protein against brucella in the murine model
background and objectives: brucellosis is an important health problem in developing countries and no vaccine is available for the prevention of infection in humans. because of clinically infectious diseases and their economic consequences in human and animals, designing a proper vaccine against brucella is desirable. in this study, we evaluated the immune responses induced by a designed recombi...
متن کاملمنابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
genetics in the 3rd millenniumجلد ۱۴، شماره ۴، صفحات ۰-۰
کلمات کلیدی
میزبانی شده توسط پلتفرم ابری doprax.com
copyright © 2015-2023